Conformationally‐changing aptamer receptors can be more attractive for future on‐body monitoring of protein markers, including T1D‐related cortisol and insulin hormones, although such systems have so far been solely reported for in‐vivo monitoring of small molecules. This evidence concerns the gene INS and type 1 diabetes mellitus.